Aortic Endograft Market Report 2024: Strategies And Recent Developments

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2052

The Business Research Company offers in-depth market insights through Aortic Endograft Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The aortic endograft market size has grown strongly in recent years. It will grow from $3.14 billion in 2023 to $3.35 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growth in medical tourism, increasing need for aortic aneurysm management, increasing number of aortic aneurysm cases, technical success of endograft implantation, increase in the number of hospitals.The aortic endograft market size is expected to see strong growth in the next few years. It will grow to $4.08 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing prevalence of abdominal aortic aneurysmsm, growing preference for minimally invasive endovascular procedures, rising geriatric population, advancements in stent-graft materials and configurations, introduction of new stent-graft products. Major trends in the forecast period include adoption of endovascular abdominal aortic aneurysm (AAA) repair devices, effectiveness of unibody and non-unibody aortic stent, product innovation.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13784&type=smp

Market Segmentation:
The aortic endograft market covered in this report is segmented -

1) By Product: Abdominal Aortic Grafts, Thoracic Aortic Grafts
2) By Material: Metallic Endografts, Polymeric Endografts
3) By Procedure: Open Surgical Repair, Endovascular Aneurysm Repair (EVAR)
4) By End User: Hospitals, Ambulatory Surgical Centers

Major Driver - Rising Incidence Of Aortic Aneurysms Fuels Expansion Of Aortic Endograft Market
The growing prevalence of aortic aneurysms is expected to propel the growth of the aortic endograft market going forward. An aortic aneurysm is a localized and abnormal dilation or bulging of the aorta, which is the largest artery in the human body. Aortic endografts are used to treat aortic aneurysms because they are less invasive than traditional open surgery. A fabric-covered metal or polymer device is inserted through a catheter, strengthening weak aortic walls and lowering the risk of rupture. For instance, in February 2023, according to Government Digital Service, a UK-based public sector information website, around 274,800 men were offered screening, with 79.0% receiving a conclusive screen and 1,794 aneurysms being found April 2021 to March 2022. Therefore, the growing prevalence of aortic aneurysms is driving the growth of the aortic aneurysm market.

Competitive Landscape:
Major companies operating in the aortic endograft market report are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., LifeTech Scientific Corporation, Altura Medical Inc., MicroVention Inc., MicroPort Scientific Corporation, CryoLife Inc., Cordis Corporation, Endologix LLC, Braile Biomédica Indústria Comércio e Representações Ltda., Nano Endoluminal S.A., Biomerics LLC, JOTEC GmbH, Lombard Medical Inc., Aptus Endosystems Inc., Lombardi SA, Cardiatis S.A., Endospan Ltd., Transcatheter Technologies GmbH

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

Top Trend - Revolutionary Medical Device For Aortic And Aortic Arch Repair
Major companies operating in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to gain a competitive edge in the market. The castor-branched aortic stent graft system is a medical device used for minimally invasive repair of the aorta and aortic arch, particularly in cases of Stanford type B aortic dissection (TBAD). For instance, in December 2021, Shanghai MicroPort Endovascular MedTech Group Co. Ltd., a China-based manufacturer of aortic and peripheral vascular intervention devices, launched the CastorTM Branched Aortic Stent-Graft System (CastorTM). The world's first stent-graft device for simultaneous aortic and aortic arch repair with minimally invasive therapy. The distinctive unibody design of this device may conform to diverse arch anatomies and provide one-time access and release. This feature guarantees the safe and easy reconstruction of the left subclavian artery while also mitigating the risk of endoleaks and promoting long-term stability.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Aortic Endograft Market Characteristics
3. Aortic Endograft Market Trends And Strategies
4. Aortic Endograft Market - Macro Economic Scenario
5. Aortic Endograft Market Size And Growth
…..
27. Aortic Endograft Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.